Tuberculosis risks for health workers in developing countriesDecember 26, 2006Latent infection with tuberculosis is common and some infected people develop the active form of the disease. Health-care workers (HCWs) can become infected, develop active disease, and c an pass their infection on to patients and others. Research published in PLoS Medicine shows that HCWs in developing countries are at particularly high risk. Over half were found to have latent TB. One third of the world's population is infected with Mycobacterium tuberculosis, the bacterium that causes TB. In most people, the bug causes no health problems and it remains latent. But about 10% of infected people develop active, potentially fatal TB disease, most commonly in their lungs. More than 90% of the world's cases of TB occur in low- and middle-income countries. The researchers Rajnish Joshi at University of California Berkeley and colleagues conducted a systematic review, which involved a comprehensive search for studies that had collected data on TB infection in health-care workers in these countries. Averaged out over the 51 studies which they found, 54% of health workers had latent TB. The TB disease rates in health-care workers were also substantially higher than those in the general population of the same countries. In high-income countries, measures are in place to reduce the TB infection risk faced by health workers. In contrast, most of the hospitals in the studies found by the researchers reported no or minimal TB control measures. The researchers say that research is needed to establish whether the control measures that have reduced TB transmission to health workers in high-income countries will work elsewhere, and whether they will be affordable.
Public Library of Science | |||||||||||||||||||||
|
Related Tuberculosis Current Events and Tuberculosis News Articles Sensitive nanowire disease detectors made by Yale scientists Yale scientists have created nanowire sensors coupled with simple microprocessor electronics that are both sensitive and specific enough to be used for point-of-care (POC) disease detection, according to a report in Nano Letters. Scientists identify gene that may make humans more vulnerable to pulmonary tuberculosis Researchers from the Genome Institute of Singapore (GIS) and its collaborators have now identified for the first time a new gene that may confer susceptibility to pulmonary tuberculosis. Gene with probable role in human susceptibility to pulmonary tuberculosis identified A new gene that may confer susceptibility to pulmonary tuberculosis has been identified by Genome Institute of Singapore (GIS) researchers and their collaborators in The Netherlands, Indonesia, United Kingdom, and the Russian Federation. Groundbreaking, lifesaving TB vaccine a step closer Researchers at Aberystwyth University, following a number of years of investment by the Biotechnology and Biological Sciences Research Council (BBSRC), have licensed ground-breaking research to a non-profit product development partnership working to develop new, more effective vaccines against Tuberculosis (TB). This development will give hope that significantly better prevention and treatment of TB will be available within the next few years. 'Deadly dozen' reports diseases worsened by climate change Health experts from the Wildlife Conservation Society today released a report that lists 12 pathogens that could spread into new regions as a result of climate change, with potential impacts to both human and wildlife health and global economies. Disease diagnosis in just 15 minutes Testing for diseases such as cancer and multiple sclerosis could soon be as simple as using a pregnancy testing kit. New way to make malaria medicine also first step in finding new antibiotics University of Illinois microbiology professor William Metcalf and his collaborators have developed a way to mass-produce an antimalarial compound, potentially making the treatment of malaria less expensive. How to differentiate abdominal tuberculosis from lymphomas? The incidence of tuberculosis is increasing. Lymphadenopathy is the most common manifestation of abdominal tuberculosis and may, in up to 55% of cases without other evidence of abdominal involvement, be easily confused with lymphomas involving abdominal lymph nodes. New insights could lead to a better pneumococcal vaccine Discovery of a new, previously unknown mechanism of immunity suggests that there may be a better way to protect vulnerable children and adults against Streptococcus pneumoniae (pneumococcal) infection, say researchers at Children's Hospital Boston and Harvard School of Public Health (HSPH). Tuberculosis drug shows promise against latent bacteria A new study has shown that an investigational drug (R207910, currently in clinical trials against multi-drug resistant tuberculosis strains) is quite effective at killing latent bacteria. This revelation suggests that R207910 may lead to improved and shortened treatments for this globally prevalent disease. More Tuberculosis Current Events and Tuberculosis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||